WAM
IDXX icon

Wakefield Asset Management’s Idexx Laboratories IDXX Stock Holding History

Wakefield Asset Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,020
Closed -$255K – 219
2018
Q3 		$255K Buy
+1,020
New +$248K 0.1% 116

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wakefield Asset Management's IDXX Position: Q4 2018 in Review

Wakefield Asset Management sold out of Idexx Laboratories (IDXX) in Q4 2018, closing a stake of 1,020 shares — an estimated $255K sold.

Wakefield Asset Management first reported a position in IDXX in Q3 2018 and held it in 1 quarter. The position peaked at $255K in Q3 2018. 670 funds tracked by Wall St. Rank hold IDXX as of Q4 2018.

  • Wakefield Asset Management reported no remaining Idexx Laboratories position as of Q4 2018 after selling out during the quarter.
  • Wakefield Asset Management sold 1,020 Idexx Laboratories shares in Q4 2018, an estimated $255K.
  • Wakefield Asset Management first reported a position in Idexx Laboratories in Q3 2018 and held it in 1 quarter.
  • Wakefield Asset Management's Idexx Laboratories position peaked at $255K in Q3 2018.
  • 670 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2018.

Based on Wakefield Asset Management's 13F filing for Q4 2018, filed 15 Feb 2019.